US NeuroSurgical Holdings Performance
| USNUDelisted Stock | USD 1.38 0.00 0.00% |
The entity owns a Beta (Systematic Risk) of 0.44, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, US NeuroSurgical's returns are expected to increase less than the market. However, during the bear market, the loss of holding US NeuroSurgical is expected to be smaller as well. US NeuroSurgical Holdings at this moment owns a risk of 0.0%. Please validate US NeuroSurgical Holdings information ratio, as well as the relationship between the value at risk and kurtosis , to decide if US NeuroSurgical Holdings will be following its current price history.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days US NeuroSurgical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, US NeuroSurgical is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 2 M | |
| Total Cashflows From Investing Activities | 63 K |
USNU |
US NeuroSurgical Relative Risk vs. Return Landscape
If you would invest 138.00 in US NeuroSurgical Holdings on October 2, 2025 and sell it today you would earn a total of 0.00 from holding US NeuroSurgical Holdings or generate 0.0% return on investment over 90 days. US NeuroSurgical Holdings is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than USNU, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
US NeuroSurgical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for US NeuroSurgical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as US NeuroSurgical Holdings, and traders can use it to determine the average amount a US NeuroSurgical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| USNU |
Based on monthly moving average US NeuroSurgical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of US NeuroSurgical by adding US NeuroSurgical to a well-diversified portfolio.
US NeuroSurgical Fundamentals Growth
USNU Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of US NeuroSurgical, and US NeuroSurgical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on USNU Pink Sheet performance.
| Return On Equity | -1.18 | |||
| Return On Asset | -0.28 | |||
| Current Valuation | 951.44 K | |||
| Shares Outstanding | 7.84 M | |||
| Price To Earning | 2.94 X | |||
| Price To Book | 2.13 X | |||
| Price To Sales | 1.39 X | |||
| Revenue | 1.06 M | |||
| EBITDA | (469 K) | |||
| Cash And Equivalents | 1.1 M | |||
| Cash Per Share | 0.14 X | |||
| Total Debt | 45 K | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 0.09 X | |||
| Cash Flow From Operations | 174 K | |||
| Earnings Per Share | (0.08) X | |||
| Total Asset | 3.69 M | |||
| Retained Earnings | (820 K) | |||
| Current Asset | 1.85 M | |||
| Current Liabilities | 1.3 M | |||
About US NeuroSurgical Performance
Assessing US NeuroSurgical's fundamental ratios provides investors with valuable insights into US NeuroSurgical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the US NeuroSurgical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
NeuroSurgical Holdings, Inc., through its subsidiaries, owns and operates stereotactic radiosurgery centers that utilize gamma knife technology. NeuroSurgical Holdings, Inc. was founded in 1993 and is based in Rockville, Maryland. US Neurosurgical operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 3 people.Things to note about US NeuroSurgical Holdings performance evaluation
Checking the ongoing alerts about US NeuroSurgical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for US NeuroSurgical Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| US NeuroSurgical is not yet fully synchronised with the market data | |
| US NeuroSurgical may become a speculative penny stock | |
| US NeuroSurgical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.06 M. Net Loss for the year was (674 K) with profit before overhead, payroll, taxes, and interest of 975 K. | |
| About 28.0% of the company outstanding shares are owned by insiders |
- Analyzing US NeuroSurgical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether US NeuroSurgical's stock is overvalued or undervalued compared to its peers.
- Examining US NeuroSurgical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating US NeuroSurgical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of US NeuroSurgical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of US NeuroSurgical's pink sheet. These opinions can provide insight into US NeuroSurgical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in USNU Pink Sheet
If you are still planning to invest in US NeuroSurgical Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the US NeuroSurgical's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |